Literature DB >> 8643271

Submandibular swelling in patients with fibrodysplasia ossificans progressiva.

H B Janoff1, M A Zasloff, F S Kaplan.   

Abstract

Fibrodysplasia ossifcans progressive (FOP) is a rare genetic disorder characterized by congenital malformation of the great toes and by progressive heterotopic ossification of soft tissues. Although ankylosis of the temporomandibular joint occurs commonly in the late stages of the disease, only one well-documented case of submandibular heterotopic ossification in a patient who had FOP exists. Twelve (11 %) of our 107 patients who have FOP had submandibular heterotopic ossification that was mistaken initially in seven of the patients for mumps, angioneurotic edema, abscess, mononucleosis, or neoplasm. Two male patients and 40 female patients ranging in age from 6 to 47 years (mean, 21 years) were studied. Ten patients survived following assiduous precautionary measures. One patient who required emergency tracheostomy and ventilatory support also survived. Another patient died of inanition from chronic swallowing difficulty. An effective treatment program includes early identification of the submandibular flare-up, nutritional support, and glucocorticoid therapy. Submandibular swelling in patients who have FOP can be a medical emergency and requires intensive precautionary measures to avoid catastrophic clinical deterioration. These measures include avoidance of lesional manipulation, airway monitoring, and aspiration precautions. Submandibular swelling should be recognized as a variable feature of FOP.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8643271     DOI: 10.1016/S0194-59989670253-X

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   5.591


  10 in total

1.  Fibrodysplasia ossificans progressiva, a heritable disorder of severe heterotopic ossification, maps to human chromosome 4q27-31.

Authors:  G Feldman; M Li; S Martin; M Urbanek; J A Urtizberea; M Fardeau; M LeMerrer; J M Connor; J Triffitt; R Smith; M Muenke; F S Kaplan; E M Shore
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

2.  Fibrodysplasia ossificans progressiva: a human genetic disorder of extraskeletal bone formation, or--how does one tissue become another?

Authors:  Eileen M Shore
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2012 Jan-Feb       Impact factor: 5.814

Review 3.  Fibrodysplasia ossificans progressiva: a current review of imaging findings.

Authors:  Adam H Bauer; Jeff Bonham; Luis Gutierrez; Edward C Hsiao; Daria Motamedi
Journal:  Skeletal Radiol       Date:  2018-02-14       Impact factor: 2.199

Review 4.  Fibrodysplasia ossificans progressiva: diagnosis, management, and therapeutic horizons.

Authors:  Robert J Pignolo; Eileen M Shore; Frederick S Kaplan
Journal:  Pediatr Endocrinol Rev       Date:  2013-06

5.  When one skeleton is enough: approaches and strategies for the treatment of fibrodysplasia ossificans progressiva (FOP).

Authors:  Frederick S Kaplan; Jay Groppe; Eileen M Shore
Journal:  Drug Discov Today Ther Strateg       Date:  2008

Review 6.  Skeletal metamorphosis in fibrodysplasia ossificans progressiva (FOP).

Authors:  Frederick S Kaplan; Qi Shen; Vitali Lounev; Petra Seemann; Jay Groppe; Takenobu Katagiri; Robert J Pignolo; Eileen M Shore
Journal:  J Bone Miner Metab       Date:  2008-11-01       Impact factor: 2.626

Review 7.  Granting immunity to FOP and catching heterotopic ossification in the Act.

Authors:  Frederick S Kaplan; Robert J Pignolo; Eileen M Shore
Journal:  Semin Cell Dev Biol       Date:  2015-12-17       Impact factor: 7.727

8.  The face signature of fibrodysplasia ossificans progressiva.

Authors:  Peter Hammond; Michael Suttie; Raoul C Hennekam; Judith Allanson; Eileen M Shore; Frederick S Kaplan
Journal:  Am J Med Genet A       Date:  2012-05-11       Impact factor: 2.802

Review 9.  Fibrodysplasia ossificans progressiva.

Authors:  Frederick S Kaplan; Martine Le Merrer; David L Glaser; Robert J Pignolo; Robert E Goldsby; Joseph A Kitterman; Jay Groppe; Eileen M Shore
Journal:  Best Pract Res Clin Rheumatol       Date:  2008-03       Impact factor: 4.098

10.  Analysis of clinical manifestations and treatment in 26 children with fibrodysplasia ossificans progressiva in China.

Authors:  Jun-Mei Zhang; Cai-Feng Li; Shuang-Ying Ke; Yu-Rong Piao; Tong-Xin Han; Wei-Ying Kuang; Jiang Wang; Jiang-Hong Deng; Xiao-Hua Tan; Chao Li
Journal:  World J Pediatr       Date:  2019-09-16       Impact factor: 2.764

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.